Nationwide estimates of SARS‐CoV‐2 infection fatality rates and numbers needed to vaccinate for COVID‐19 vaccines in 2024 in Austria
In 2024 in Austria, SARS-CoV-2 IFR was low and NNV and LYS of COVID-19 vaccinations correspondingly non-favorably high, even for very old individuals.
Authors
- Stefan Pilz (ORCID: https://orcid.org/0000-0002-7959-1311)
- Martin Sprenger (ORCID: https://orcid.org/0000-0002-7232-6515)
- John P. A. Ioannidis (ORCID: https://orcid.org/0000-0003-3118-6859)
- Uwe Riedmann (ORCID: https://orcid.org/0000-0002-2541-9604)
Institutions
- Medical University of Graz (AT)
- Stanford Health Care (US)
- Stanford Medicine (US)
- Innovative Research (United States) (US)
- Stanford University (US)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1111/eci.70135
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Austrian Science Fund